Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law 80+ peptides are fda approved. most people aren't using any of them. bpc 157, tb 500, ipamorelin none completed phase 3 trials. the feb 2026 reclassification to category 1 restored compounding access for 14 Sermorelin: Benefits, FDA Status & Safety in 2025 Healthon 2023 FDA approvals: unprecedented volume at moderate value